Cyclin D1 Based TPF Induction Chemotherapy for Oral Squamous Cell Carcinoma Patients at Clinical N2 Stage

Status:
Recruiting

Trial end date:
2025-12-01

Target enrollment:

Participant gender:

The purpose of this study is to To confirm the predictive value of CCND1 for TPF induction in cN2 patients with OSCC

Phase 2

Shanghai Jiao Tong University School of Medicine

Cisplatin
Docetaxel